TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Skandinavisk BioTech AB
Closing information (x1000 EUR)
Closing information | 2023/08 | 2022/08 | 2021/08 |
Turnover |
505
|
570
|
395 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
69
|
90
|
106 |
EBITDA |
61
|
89
|
102 |
Total assets |
812
|
821
|
737 |
Current assets |
604
|
614
|
535 |
Current liabilities |
85
![]() |
85
|
49 |
Equity capital |
670
|
683
|
643 |
- share capital |
8
|
9
|
10 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Solvency |
82.5%
|
83.2%
|
87.2% |
Turnover per employee |
505
|
570
|
395 |
Profit as a percentage of turnover |
13.7%
|
15.8%
|
26.8% |
Return on assets (ROA) |
8.5%
|
11.0%
|
14.4% |
Current ratio |
710.6%
|
722.4%
|
1091.8% |
Return on equity (ROE) |
10.3%
|
13.2%
|
16.5% |
Change turnover |
-9
|
194
|
-31 |
Change turnover % |
-2%
|
52%
|
-7% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.